Garaci, E <br/><br/>
Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2a.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Dec 1995 
 - 2403-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/0959-8049(95)00477-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--therapy<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Lung Neoplasms--therapy<br/>Male<br/>Middle Aged<br/>Recombinant Proteins<br/>Remission Induction<br/>Survival Analysis<br/>Thymalfasin<br/>Thymosin--administration & dosage